| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Iterum Therapeutics plc | Chief Medical Officer | Ordinary Shares | 10,369 | $14,517 | $1.40 | 01 Dec 2023 | Direct |
| Iterum Therapeutics plc | Chief Medical Officer | Stock Option (Right to Buy) | 75,000 | 31 Mar 2023 | Direct | ||
| Iterum Therapeutics plc | Chief Medical Officer | Restricted Share Units | 16,666 | 01 Dec 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| ITRM | Iterum Therapeutics plc | 01 Dec 2023 | 3 | -$6,218 | 4 | Chief Medical Officer | 04 Dec 2023, 17:00 |
| ITRM | Iterum Therapeutics plc | 31 Mar 2023 | 1 | $0 | 4 | Chief Medical Officer | 03 Apr 2023, 20:00 |
| ITRM | Iterum Therapeutics plc | 01 Dec 2022 | 3 | -$4,442 | 4 | Chief Medical Officer | 05 Dec 2022, 16:00 |
| ITRM | Iterum Therapeutics plc | 10 Dec 2021 | 2 | $0 | 4 | Chief Medical Officer | 14 Dec 2021, 16:00 |
| ITRM | Iterum Therapeutics plc | 01 Dec 2021 | 0 | $0 | 3 | Chief Medical Officer | 13 Dec 2021, 17:00 |